14 August 2023
Episode 462
15 minutes
There have been plenty of recent headlines about new, more efficacious weight-loss drugs to treat excess body fat. The global number of people with obesity continues to rise at pace – and shows no signs of falling for years to come. So what does this mean in terms of trends and opportunities for smart investors?
14 August 2023
Share episode
DownloadWant more radio episodes like these in your inbox?
Sign up to Monocle’s email newsletters to stay on top of news and opinion, plus the latest from the magazine, radio, film and shop.
The Bulletin with UBS - latest episodes
UBS European Conference review part two: equity markets
The latest in our series of programmes unpacking some of the key panels and themes from the 2023 edition of the UBS European Conference. This week we turn to equity markets and hear from James Arnold, global co-head of…
Focus on China
What are the compelling opportunities that remain at the end of China’s multi-decade period of high growth? We focus on the country and explore its importance to investors – and to the world – through the prism of UBS’s…
UBS European Conference review part one: US and European outlook
The first in an occasional series exploring some of the key panels and themes from the 2023 edition. Ahead of programmes focused on equity markets and gender equality, we begin with the outlook for the US courtesy of UBS…
Another “Roaring Twenties” for the US?
We are joined by two of the authors of a new report from the Chief Investment Office of UBS Global Wealth Management that explores whether the US is set for another “Roaring Twenties”. The economy has evolved in unexpected…
The Art Basel & UBS Survey of Global Collecting 2023
Insights into the behaviours and attitudes of high-net-worth art collectors around the world. Discover why there was a greater engagement with research-based acquisitions and why these collectors are optimistic about the…
From the archive: Daniel Kahneman
Another chance to hear this special episode featuring the brilliant Daniel Kahneman. To address the big questions that shape our world, UBS has sought out a number of economic science Nobel laureates and asked them to share…
Can natural capital accounting help to meet biodiversity goals?
William Nicolle from the UBS Sustainability & Impact Institute explains how this economic approach could help to address the urgent challenge of global biodiversity loss. With biodiversity diminishing at an alarming pace…
Global Visionaries special: Financing Alliance for Health
Angela Gichaga is the CEO of the Financing Alliance for Health and one of the inspirational innovators that UBS supports and celebrates through its Global Visionaries programme. Angela is joined at Monocle’s HQ in Zürich…
Electric vehicles: Q-Series teardown of the BYD Seal
UBS Q-Series research connects the dots across asset classes, geographies and sectors. Today we hear from the analysts behind UBS Evidence Lab’s newest teardown of the electric car. In this most recent iteration, the EV in…
‘Rethink, Rebuild, Reimagine’
A special edition of the programme exploring ‘Rethink, Rebuild, Reimagine: The Untapped Opportunity and Overlooked Risk in Buildings and Structures’, a new white paper from the UBS Sustainability and Impact Institute. Two…
‘The UBS Global Real Estate Bubble Index 2023’
We discuss UBS’s annual report that assesses urban housing markets around the world and gauge the “bubble risk” in residential property markets in 25 major cities. The 2023 edition looks at the effect of the abrupt end of…
European Central Banks
We discuss the decision by the ECB to raise interest rates to an all-time high of 4 per cent. What will the impact be on the Eurozone economy? And how will the Swiss National Bank react? Dean Turner and Tom Flury explain…
What happens when AI takes over?
Forget the recent hype surrounding artificial intelligence (AI) and join us for a look at the clear economic application for the new technology. Paul Donovan of UBS explains why the economics of AI are also those of disr…
“Marketheimer”
Millions of global theatre-goers have enjoyed the “Barbenheimer” cinematic experience this summer. But what happens if you apply the idea of two apparently incongruous events happening at the same time to markets as well…
Global Visionaries special: Perkins School for the Blind
Dave Power is the president and CEO of Perkins School for the Blind, as well as one of the inspirational innovators who UBS supports and celebrates through its Global Visionaries programme. Power and his team provide world…
